MYRIAD GENETICS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
MYRIAD GENETICS, INC. (MYGN) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $885.80 million as of 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-03-01
- 2022-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $885.80M.
- 2022-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $916.60M.
- 2022-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $947.40M.
- 2022-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $950.10M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2022-12-31 | $885.80M 10-K · filed 2023-03-01 | |
| 2022-09-30 | $916.60M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $947.40M 10-Q · filed 2022-11-02 | |
| 2022-03-31 | $950.10M 10-Q · filed 2022-11-02 | |
| 2021-12-31 | $967.80M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $968.50M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $902.40M 10-Q · filed 2022-11-02 | |
| 2021-03-31 | $875.20M 10-Q · filed 2022-11-02 | |
| 2020-12-31 | $881.00M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $909.30M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $918.20M 10-K · filed 2023-03-01 | |
| 2020-03-31 | $967.20M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $1.08B 10-Q · filed 2021-11-04 | |
| 2019-09-30 | $1.07B 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $1.09B 10-K · filed 2023-03-01 | |
| 2019-03-31 | $1.08B 10-Q · filed 2020-05-06 | $1.08B 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.06B 10-Q · filed 2020-05-06 | $1.06B 10-Q · filed 2019-02-06 |
| 2018-09-30 | $1.10B 10-Q · filed 2020-05-06 | |
| 2018-06-30 | $966.10M 10-K · filed 2022-02-25 | $964.90M 10-K · filed 2018-08-24 |
| 2018-03-31 | $932.80M 10-Q · filed 2019-05-08 | $948.40M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $900.90M 10-Q · filed 2019-05-08 | $914.20M 10-Q · filed 2018-02-07 |
| 2017-09-30 | $858.40M 10-Q · filed 2019-05-08 | $870.60M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $767.40M 10-KT · filed 2021-03-16 | $777.80M 10-K · filed 2017-08-09 |
| 2017-03-31 | $747.90M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $732.70M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $735.30M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $741.70M 10-K · filed 2019-08-13 | $748.10M 10-Q · filed 2016-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |